Skip to main content
Scheme 2 | EJNMMI Radiopharmacy and Chemistry

Scheme 2

From: Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

Scheme 2

Conjugation of 13 with its respective chelator and their labelling with 64Cu. a (tBu3)-NODA-GA, HATU, HOBt, DIPEA, abs. DMF, r.t., 3 h, 46%; b 14a, TFA/CH2Cl2/TES/H2O (20:20:8:7), r.t., 40 h, 44%; c CB-TE2A, HATU, HOBt, DIPEA, abs. DMF, r.t., 5 h, 85%; d glutaric anhydride, DIPEA, abs. DMF, r.t., 16 h, 84%; e 16a, DiAmSar, HATU, HOBt, DIPEA, abs. DMF, r.t., 3 h, 77% for 16 and 9% for 17; f [64Cu]CuCl2, 1 M HEPES (adjusted to pH 4.5 with 1 M HCl), 50 °C, 10 min; g [64Cu]CuCl2, 1 M HEPES (adjusted to pH 4.5 with 1 M HCl), 95 °C, 60 min; h 1 M HEPES, r.t., 10 min

Back to article page